Utility of adjuvant immunotherapy in high-risk non-metastatic renal cell carcinoma: A real-world experience using national cancer database analysis

被引：0
|
作者：
Garg, H. [1 ]
Bhandari, M. [2 ]
Noel, O. V. [1 ]
Dursun, F. [1 ]
Liss, M. A. [1 ]
Kaushik, D. [1 ]
Ramamurthy, C. [3 ]
Mansour, A. M. [1 ]
机构：
[1] Univ Texas Hlth San Antonio, Dept Urol, San Antonio, TX USA
[2] Univ Texas Hlth San Antonio, Dept Populat Hlth Sci, San Antonio, TX USA
[3] Univ Texas Hlth San Antonio, Dept Med Oncol, San Antonio, TX USA
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0475
引用
收藏
页码：S678 / S679
页数：2
相关论文
共 50 条
  • [41] Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: Analysis of the STAR TOR registry
    Moran, Michael
    Hubbe, Marcus
    Rink, Michael
    Bergmann, Lothar
    Strauss, Arne
    Bernhardt, Stephan
    Schmid, Marianne
    Boegemann, Martin
    Schlack, Katrin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [42] Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma
    Donskov, Frede
    Pinto, Cathy Anne
    Predoiu, Raluca
    Fox, Claire
    Georgsen, Jeanette Baehr
    Skaarup, Katrine
    Burcu, Mehmet
    Perini, Rodolfo
    Steiniche, Torben
    ACTA ONCOLOGICA, 2022, 61 (10) : 1268 - 1277
  • [43] Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials
    Karakiewicz, Pierre I.
    Zaffuto, Emanuele
    Kapoor, Anil
    Basappa, Naveen S.
    Bjarnason, Georg A.
    Blais, Normand
    Breau, Rodney H.
    Canil, Christina
    Drachenberg, Darrel
    Hotte, Sebastien J.
    Jeldres, Claudio
    Jewett, Michael A. S.
    Kassouf, Wassim
    Kollmannsberger, Christian
    Lavallee, Luke T.
    Maloni, Ranjena
    Patenaude, Francois
    Pouliot, Frederic
    Reaume, M. Neil
    Sabbagh, Robert
    Shayegan, Bobby
    So, Alan
    Soulieres, Denis
    Tanguay, Simon
    Wood, Lori
    Bandini, Marco
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (06): : 173 - 180
  • [44] Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database
    Rajkumar, S. Vincent
    Mateos, Maria-Victoria
    Schaeffer, Marcy
    Lin, Xiwu
    Bathija, Sacheeta
    Gupta-Werner, Niodita
    Lam, Annette
    Carson, Robin
    Dennis, Robyn
    Kaila, Shuchita
    Matt, Kathryn
    Duran, Joana
    Lonial, Sagar
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [45] Real-World Experience of Immunotherapy from India in Recurrent Squamous Cell Carcinoma of Head and Neck Cancer
    Abbas, Waseem
    Gupta, Saurabh
    Goel, Vineeta
    Rao, Ranga R.
    Pankaj, Promila
    Tripathi, Devashish
    Patil, Pratik P.
    Popli, Swati
    SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (02) : 72 - 75
  • [46] Real-World Outcomes in Non-metastatic Non-small Cell Lung Cancer (NSCLC): An I-O Optimise MultiCountry Analysis
    Daumont, M. J.
    Rault, C.
    Baltus, H.
    Ding, P. Q.
    Emanuel, G.
    Lucherini, S.
    Vo, L.
    Greystoke, A.
    Katalinic, A.
    Leal, C.
    Muwaffak, M.
    Oskarsdottir, G. N.
    Waldmann, A.
    Wagenius, G.
    Cheung, W. Y.
    Munro, R.
    Schoemaker, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S269 - S270
  • [47] Cabozantinib real-world effectiveness in the second-line setting of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Zarba, Martin
    O'Sullivan, Dylan
    El Hajj Chehade, Razane
    Mckay, Rana R.
    Pal, Sumanta Kumar
    Beuselinck, Benoit
    Donskov, Frede
    Lalani, Aly-Khan A.
    Crumbaker, Megan
    Li, Haoran
    Alva, Ajjai Shivaram
    Powles, Thomas
    Takemura, Kosuke
    Kollmannsberger, Christian K.
    Wong, Shirley S.
    Wood, Lori A.
    de Velasco, Guillermo
    Cheung, Winson Y.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [48] Real-world experience of axitinib as second-line treatment in metastatic renal cell carcinoma: Analysis of the Swedish population.
    Strambi, Angela
    Jakobsson, Maria
    Nilsson, Fredrik
    Arpegard, Johannes
    Dalen, Johan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [49] Improved Survival after Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era: An Analysis of the National Cancer Database Comment
    Laguna, M. Pilar
    JOURNAL OF UROLOGY, 2021, 205 (01): : 301 - 302
  • [50] Cabozantinib in non-clear cell metastatic renal cell carcinoma and sarcomatoid renal cell carcinoma: Real-world data from the CABOREAL study
    Flechon, A.
    Chevreau, C. M.
    Topart, D.
    Gravis, G.
    Oudard, S.
    Tourani, J. M.
    Geoffrois, L.
    Meriaux, E.
    Thiery-Vuillemin, A.
    Barthelemy, P.
    Ladoire, S.
    Laguerre, B.
    Bourouina, R.
    Perrot, V.
    Escudier, B.
    Gross-Goupil, M.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S572 - S573
12345